Company profile: Microbiome Insights
1.1 - Company Overview
Company description
- Provider of end-to-end microbiome DNA sequencing services and state-of-the-art bioinformatic analysis. Offerings include 16S V4 amplicon sequencing for taxonomic profiling, shotgun metagenomic sequencing for species-level and functional insights, short-chain fatty acid analysis in stool, qPCR for absolute abundance, and comprehensive bioinformatics processing and reporting.
Products and services
- Shotgun Metagenomic Sequencing: Whole-sample sequencing enabling species-level identification and functional analysis of all DNA present in a sample for microbiome studies
- 16S V4 Amplicon Sequencing: Region-specific sequencing delivering taxonomic profiling of prokaryotic communities using the 16S V4 region, compatible with various sample types
- Bioinformatics Analysis: State-of-the-art data processing and comprehensive report generation for sequencing projects, offering insights into microbial communities for researchers and clinicians
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Microbiome Insights
Detraxi
HQ: United States
Website
- Description: Provider of proprietary biotechnology solutions addressing blood and organ shortages, including alternatives to whole or derived blood products aimed at eliminating the need for donations; technologies to preserve and regenerate organs outside the body to extend transplant viability; regenerative medicine to engineer organs and reduce reliance on donated tissues; and enhanced diagnostics to better preserve samples and improve test accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Detraxi company profile →
Echelon Biosciences
HQ: United States
Website
- Description: Provider of tools and reagents for biomedical research and drug discovery, including Membrane Lipid Strips for protein-lipid interaction assays; PIP3 Mass ELISA for PI(3,4,5)P3 detection; lipid antibodies; Hyaluronidase Activity ELISA; neuroscience resources for nervous system studies; and cell membrane resources for lipid-protein interactions and membrane analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Echelon Biosciences company profile →
BridGene Biosciences
HQ: United States
Website
- Description: Provider of chemoproteomics-driven small-molecule discovery and development via the IMTAC platform that screens small molecules against all proteins in live cells; a covalent small-molecule library targeting diverse amino acids; live-cell screening and quantitative mass spec analysis services; and drug development for undruggable targets, particularly in oncology, with partnerships such as Takeda.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BridGene Biosciences company profile →
Tentarix
HQ: United States
Website
- Description: Provider of protein therapeutics and discovery platforms leveraging synthetic biology, including the Tentacles platform for multifunctional, conditionally active antibody-based biologics that activate immune cells and modulate disease while minimizing safety concerns; CellSurf to understand cell surface proteomes; HuTARG mammalian display to discover fully human binders; and FunctionSeq high-throughput screening of multifunctional biologics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tentarix company profile →
InSphero
HQ: Switzerland
Website
- Description: Provider of organotypic biological in vitro 3D microtissues and microtissue-based assays for biochemical compound screening and predictive drug testing, offering human prostate and mammary carcinoma and rat liver microtissues, plus services including compound toxicity testing, cell-invasion assays, and stem-cell research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InSphero company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Microbiome Insights
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Microbiome Insights
2.2 - Growth funds investing in similar companies to Microbiome Insights
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Microbiome Insights
4.2 - Public trading comparable groups for Microbiome Insights
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →